Patent details

EP3113772 Title: TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS

Basic Information

Publication number:
EP3113772
PCT Application Number:
US2015019535
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157592544
PCT Publication Number:
WO2015134998
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS
French Title of Invention:
PYRAZOLES SUBSTITUÉS PAR UN TRIFLUOROMETHYLE EN TANT QU`INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE HUMAINE
German Title of Invention:
TRIFLUOROMETHYL SUBSTITUIERTE PYRAZOLE ALS MENSCHLICHE PLASMAKALLIKREINHEMMER
SPC Number:
LUC00233

Dates

Filing date:
09/03/2015
Grant date:
09/09/2020
EP Publication Date:
11/01/2017
PCT Publication Date:
11/09/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/09/2020
EP B1 Publication Date:
09/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/09/2020
 
 

Name:
Biocryst Pharmaceuticals, Inc.
Address:
4505 Emperor Blvd., Durham, North Carolina 27703, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
10/12/2020
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
KOTIAN, Pravin L.
Address:
United States (US)

2

Name:
ZHANG, Weihe
Address:
United States (US)

3

Name:
CHINTAREDDY, Venkat R.
Address:
United States (US)

4

Name:
BABU, Yarlagadda S.
Address:
United States (US)

5

Name:
WU, Minwan
Address:
United States (US)

6

Name:
KUMAR, V. Satish
Address:
United States (US)

Priority

1

Priority Number:
201461949808 P
Priority Date:
07/03/2014
Priority Country:
United States (US)

2

Priority Number:
201461981515 P
Priority Date:
18/04/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/415; A61P 7/02; C07D 231/14; C07D 401/04; C07D 401/14; C07D 403/04; C07D 403/12; C07D 405/12; C07D 413/04; C07D 413/12; C07D 417/12;

Publication

European Patent Bulletin

1

Issue number:
202037
Publication date:
09/09/2020
Description:
Grant (B1)

2

Issue number:
202039
Publication date:
23/09/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202045
Publication date:
04/11/2020
Description:
Inventor(s) changed

4

Issue number:
202048
Publication date:
25/11/2020
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
20/03/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
SUN IP LLC
Filing date Document type Number of pages
10/12/2020 Power Of Attorney 2
10/12/2020 Outgoing Correspondence 1